D. E. Shaw & Co., Inc. Celcuity Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.35 - $10.11 $29,644 - $56,019	-5,541 Reduced 29.56%	13,202 $120,000
Q1 2022 May 16, 2022	BUY	$7.93 - $13.33 $20,483 - $34,431	2,583 Added 15.98%	18,743 $175,000
Q4 2021 Feb 14, 2022	SELL	$11.96 - $19.35 $32,280 - $52,225	-2,699 Reduced 14.31%	16,160 $213,000
Q3 2021 Nov 15, 2021	BUY	$17.35 - $24.87 $327,203 - $469,023	18,859 New	18,859 $339,000

107

30.3M

30.8K

152K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $190M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.